This pilot program is designed to encourage and facilitate novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings. Projects must demonstrate high translational potential with a clear path to subsequent grant support, new company formation, licensing, not-for-profit partnering, or other channels.
Duke CTSI and UNC-CH are interested in the following types of translational research projects, with an emphasis on inter-disciplinary collaborations that test generalizable solutions to translational research problems:
- Generates initial or basic discoveries relevant to human health or disease
- Applies or accelerates discovery into testing in clinical or population settings
- Development and/or evaluation of the evidence base that changes practice
- Investigates how practice improves health policy, health outcomes, and the health of populations
While we are interested in a broad range of translational research, Duke and UNC are particularly interested in preliminary studies to inform the prevention and treatment of opiate use disorder, one of the highest priority conditions for our state.
- Application Submission Deadline: November 18, 2019
Selection of Awardees: December 2019 / January 2020
Funding Period: The budget period is for 12 months beginning between January 1 and May 1, 2020 and ending no later than April 30, 2021.
Duke CTSI and NC TraCS pilot grant awards are not meant as bridge funding or as supplementary funding for existing projects.
- Proposed projects must involve a lead investigator from Duke and a lead investigator from UNC-CH. Proposals are encouraged from new teams of investigators from different disciplines. Applicants at each institution must have a full-time faculty appointment.
- Interested investigators who need assistance identifying collaborators at Duke or UNC-CH can use the Reach NC tool (http://reachnc.org/) or contact either Duke CTSI (email@example.com) or NC TraCS (firstname.lastname@example.org) for assistance.